Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2017 | Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections | Kamm?ller M.; TSEN-FANG TSAI ; Griffiths C.E.M.; Kapoor N.; Kolattukudy P.E.; Brees D.; Chibout S.-D.; Safi J.; Jr.; Fox T. | Clinical and Translational Immunology | 63 | 57 |